Amedeo Capetti

3.1k total citations
74 papers, 1.5k citations indexed

About

Amedeo Capetti is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Amedeo Capetti has authored 74 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 52 papers in Virology and 19 papers in Emergency Medicine. Recurrent topics in Amedeo Capetti's work include HIV Research and Treatment (51 papers), HIV/AIDS drug development and treatment (49 papers) and HIV/AIDS Research and Interventions (29 papers). Amedeo Capetti is often cited by papers focused on HIV Research and Treatment (51 papers), HIV/AIDS drug development and treatment (49 papers) and HIV/AIDS Research and Interventions (29 papers). Amedeo Capetti collaborates with scholars based in Italy, South Africa and United States. Amedeo Capetti's co-authors include Giuliano Rizzardini, Mario Clerici, Maria Vittoria Cossu, Stefano Rusconi, Daria Trabattoni, Stefania Piconi, Dorte Eskesen, Lillian Jespersen, Philip C. Calder and Paola Meraviglia and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Amedeo Capetti

73 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amedeo Capetti Italy	21	956	719	319	291	243	74	1.5k
Jing Xie China	23	1.1k 1.2×	383 0.5×	380 1.2×	224 0.8×	370 1.5×	80	2.1k
Sergio Serrano‐Villar Spain	24	1.2k 1.3×	957 1.3×	497 1.6×	777 2.7×	702 2.9×	102	2.4k
Matti Ristola Finland	23	1.0k 1.1×	667 0.9×	690 2.2×	989 3.4×	285 1.2×	67	2.2k
Raquel Martínez Switzerland	23	703 0.7×	668 0.9×	249 0.8×	153 0.5×	412 1.7×	40	1.5k
Jean‐Luc Meynard France	19	926 1.0×	551 0.8×	340 1.1×	206 0.7×	64 0.3×	42	1.3k
Hector Bonilla United States	23	1.1k 1.1×	238 0.3×	638 2.0×	180 0.6×	293 1.2×	63	2.2k
Jaime Andrade‐Villanueva Mexico	18	1.8k 1.9×	1.3k 1.8×	329 1.0×	581 2.0×	210 0.9×	64	2.1k
Mathias Bruyand France	19	655 0.7×	278 0.4×	283 0.9×	337 1.2×	66 0.3×	35	1.1k
Lucia Taramasso Italy	21	774 0.8×	288 0.4×	456 1.4×	272 0.9×	114 0.5×	97	1.3k
Amanda Peppercorn United States	17	744 0.8×	351 0.5×	366 1.1×	101 0.3×	168 0.7×	39	1.1k

Countries citing papers authored by Amedeo Capetti

Since Specialization

Citations

This map shows the geographic impact of Amedeo Capetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amedeo Capetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amedeo Capetti more than expected).

Fields of papers citing papers by Amedeo Capetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amedeo Capetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amedeo Capetti. The network helps show where Amedeo Capetti may publish in the future.

Co-authorship network of co-authors of Amedeo Capetti

This figure shows the co-authorship network connecting the top 25 collaborators of Amedeo Capetti. A scholar is included among the top collaborators of Amedeo Capetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amedeo Capetti. Amedeo Capetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lovaglio, Pietro Giorgio, Chiara Mariani, Paolo Berta, et al.. (2024). Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study. BMJ Open. 14(2). e075185–e075185. 1 indexed citations

Fabbiani, Massimiliano, Barbara Rossetti, Arturo Ciccullo, et al.. (2023). Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. Viruses. 15(5). 1123–1123. 4 indexed citations

Ciccullo, Arturo, Gianmaria Baldin, Vanni Borghi, et al.. (2022). Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort. Viruses. 14(1). 163–163. 7 indexed citations

Piscaglia, Marco, Maria Vittoria Cossu, Matteo Passerini, et al.. (2021). Emerging drugs for the treatment of HIV/AIDS: a review of 2019/2020 phase II and III trials. Expert Opinion on Emerging Drugs. 26(3). 219–230. 2 indexed citations

Fabbiani, Massimiliano, Barbara Rossetti, Arturo Ciccullo, et al.. (2021). Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort. HIV Medicine. 22(9). 843–853. 20 indexed citations

Ciccullo, Arturo, Vanni Borghi, Andrea Giacomelli, et al.. (2021). Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding. JAIDS Journal of Acquired Immune Deficiency Syndromes. 88(3). 234–237. 23 indexed citations

Ciccullo, Arturo, Gianmaria Baldin, Maria Vittoria Cossu, et al.. (2021). Short Communication: Efficacy and Safety of Dolutegravir Plus Lamivudine as a First-Line Regimen in Clinical Practice. AIDS Research and Human Retroviruses. 37(6). 486–488. 7 indexed citations

Borghetti, Alberto, Arturo Ciccullo, Gianmaria Baldin, et al.. (2020). Shall We Dance? Extending TANGO’s Results to Clinical Practice. Clinical Infectious Diseases. 71(7). e200–e201. 9 indexed citations

Baldin, Gianmaria, Arturo Ciccullo, Stefano Rusconi, et al.. (2019). Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study.. PubMed. 27(4). 410–414. 6 indexed citations

10.

Baldin, Gianmaria, Arturo Ciccullo, Stefano Rusconi, et al.. (2019). Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients. International Journal of Antimicrobial Agents. 54(6). 728–734. 40 indexed citations

11.

Borghetti, Alberto, Gianmaria Baldin, Francesca Lombardi, et al.. (2018). Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication. HIV Medicine. 19(7). 452–454. 37 indexed citations

12.

Baldin, Gianmaria, Arturo Ciccullo, Amedeo Capetti, et al.. (2018). Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study. HIV Medicine. 20(2). 164–168. 14 indexed citations

13.

Giacomet, Vania, Maria Vittoria Cossu, Amedeo Capetti, Gianvincenzo Zuccotti, & Giuliano Rizzardini. (2018). An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents. Expert Opinion on Pharmacotherapy. 20(3). 269–276. 3 indexed citations

14.

Capetti, Amedeo, Maria Vittoria Cossu, & Giuliano Rizzardini. (2015). Darunavir/cobicistat for the treatment of HIV-1: a new era for compact drugs with high genetic barrier to resistance. Expert Opinion on Pharmacotherapy. 16(17). 2689–2702. 17 indexed citations

15.

Calcagno, Andrea, Chiara Montrucchio, Amedeo Capetti, et al.. (2015). Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. Current HIV Research. 14(1). 54–60. 6 indexed citations

16.

Bruno, Raffaele, Giuseppe Cariti, Paola Nasta, et al.. (2014). OPERA : responses to peginterferon and ribavirin therapy in a subgroup of interferon‐naïve patients with HIV / HCV genotype 2/3 co‐infection in Italy. Liver International. 35(1). 120–129. 4 indexed citations

17.

Capetti, Amedeo & Giuliano Rizzardini. (2014). Cobicistat: a new opportunity in the treatment of HIV disease?. Expert Opinion on Pharmacotherapy. 15(9). 1289–1298. 5 indexed citations

18.

Clementi, Emilio, Maria Vittoria Cossu, Dario Cattaneo, et al.. (2014). Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers. Drug Design Development and Therapy. 8. 411–411. 8 indexed citations

19.

Riva, Chiara, Alessia Lai, Ilaria Caramma, et al.. (2010). Transmitted HIV Type 1 Drug Resistance and Non-B Subtypes Prevalence among Seroconverters and Newly Diagnosed Patients from 1992 to 2005 in Italy. AIDS Research and Human Retroviruses. 26(1). 41–49. 15 indexed citations

20.

Rizzardini, Giuliano & Amedeo Capetti. (2006). Switch to abacavir-based triple nucleoside regimens in HIV-1 infected patients never treated with suboptimal antiretroviral therapy: a review.. PubMed. 12(12). RA269–276. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact